palliative-care-2016_posters-accepted-abstracts

10 / 15

Page 59
Palliative Care 2016
September 29-30, 2016
Volume 6 Issue 5(Suppl) J Palliat Care Med
ISSN: 2165-7386 JPCM, an open access journal
conferenceseries .com
September 29-30, 2016 Toronto, Canada
2nd Global Congress onHospice & Palliative Care
J Palliat Care Med 2016, 6:5(Suppl)
THE CHAMPLAIN SYMPTOM MANAGEMENT KIT: ENHANCING EOL CARE BY PROVIDING
TIMELYACCESS TO MEDICATIONS AND SUPPLIES IN THE HOME
France Perussea, Genevieve Lalumiere a and Paula Grecoa
aChamplain CCAC, Canada
Adequate pain and symptom management is an essential component of palliative and end-of-life care and has a direct
impact on patient and caregiver experience. In September 2014, the Champlain CCAC, in collaboration with regional
pharmacies, service provider organizations, the Regional Palliative Consultation Team and community palliative care
physicians, introduced a Champlain Wide Pain and Symptom Management Kit (SMK). The SMK is a standard package of
medications and related medical supplies placed in the home of a patient who is approaching the end-of-life for the purpose of
relieving unanticipated or rapidly escalating symptoms in a timely manner.
The overall purpose of the Kit is to facilitate pain and symptom management at the end of life by providing timely access
to medications and supplies, therefore optimizing patient's chances of remaining at home until death; enhancing informal
caregiver support in the home; and enabling nurses to manage symptoms without needing immediate access to a physician,
which is often difficult.
One year after implementation, a robust evaluation was completed. The results demonstrate a positive impact of the Kit on
patients, caregivers, and provider experience, including reduction of caregiver anxiety and increased self-efficacy. The results
also demonstrate a positive impact on a number of outcome measures, such as reduced emergency department visits and
hospital admissions, and increased patient deaths in their preferred location.
THE SYSTEMATIC EARLY INTEGRATION OF PALLIATIVE CARE INTO MULTIDISCIPLINARY
ONCOLOGY CARE IN THE HOSPITAL SETTING (IPAC), A RANDOMIZED CONTROLLED
TRIAL: THE STUDY PROTOCOL
Gaëlle Vanbutselea, Simon Van Bellea, Martine De Laata, Veerle Surmont a, Karen Geboesa, Kim Eeclooa, Keon Pardona and Luc Deliensa
eGhent University, Belgium
Background: Previous studies in the US and Canada show the positive impact of early palliative care programs for advanced cancer
patients on quality of life (QoL) and even survival time. There has been a lack of similar research in Europe. In order to generalize
the findings from the US and Canada research on a larger scale, similar studies are needed in different countries with different care
settings, such as Belgium. Method: A randomized controlled trial (RCT) is being conducted as follows: 186 patients with advanced
cancer were recruited from the departments of Medical Oncology, Digestive Oncology and Thoracic Oncology of the
Ghent University Hospital. Patients are randomized to either systematic early integration of palliative care in standard oncology
care or standard oncology care alone. Patients and informal caregivers are asked to fill out questionnaires on QoL, mood, illness
understanding and satisfactionwith care at baseline, 12 weeks and every six weeks thereafter. Other outcomemeasures are end-of-life
care decisions and overall survival time. Results concerning baseline characteristics are due June 2016.
Discussion: This is the first RCT in the Belgian health care setting to evaluate the effect of systematic early integration of palliative
care for advanced cancer patients. The results will enable us to evaluate whether systematic early integration of palliative care has
positive effects on QoL, mood and patient illness- Understanding and which components of the intervention contribute to these
effects. Trial registration Clinical trials.gov Identifier: NCT01865396, registered 24th of May, 2013.